Liquid chromatographic method for the determination of rosiglitazone in human plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 788, Issue 1, 2003, Pages 37-44

  Kolte, B L ^a,b   Raut, B B ^a,b   Deo, A A ^a   Bagool, M A ^a   Shinde, D B ^b  

^a New Drug Discovery   (India)

^b DR BABASAHEB AMBEDKAR MARATHWADA UNIVERSITY   (India)

Author keywords

Rosiglitazone

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH EFFECTS; ULTRAVIOLET DETECTORS;

HUMAN PLASMA;

BIOMEDICAL ENGINEERING;

BUFFER; METHANOL; PHOSPHATE; PIOGLITAZONE; ROSIGLITAZONE;

ACCURACY; ARTICLE; COLUMN CHROMATOGRAPHY; EXPERIMENTAL TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MONITORING; PLASMA; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; STANDARD;

EID: 0037420712     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1570-0232(02)01011-5     Document Type: Article

References (11)

1. Patel J., Miller E., Patwardhan R. Diabetes. 47:(Suppl. 1):1998;A17.
2. Young P.W., Buckle D.R., Cantello B.C., Chapman H., Clapham J.C., Coyle P.J., Haigh D., Hindley R.M., Holder J.C., Kallender H., Latter A.J., Lawrie K.W.M., Mossakowska D., Murphy G.J., Roxbee Cox L., Smith S.A. J. Pharmacol. Exp. Ther. 284:1998;751.
3. Freed M.I., Allen A., Jorkasky D.K., DiCicco R.A. Eur. J. Clin. Pharmacol. 55:1999;53.
4. Miller A.K., Inglis A.L., Thompson K., Davie C.C., Schenker S., Blum R., Jorkasky D., Freed M.I. Clin. Pharmacol. Ther. 65:(2):1999;186.
5. Cox P.J., Ryan D.A., Hollis F.J., Harris A.M., Miller A.K., Vousden M., Cowley H. Drug Metab. Dispos. 28:(7):2000;772.
6. Muxlow A.-M., Fowles S., Russell P. J. Chromatogr. B. 752:2001;77.
7. Gaffney M.H., Allen G.D., Abbott R.W., Deeks N.J., Hollis F.J., Rhodes G. Ried E., Hill H.M., Wilson I.D. Methodological Surveys in Bioanalysis of Drugs. Vol. 23:1994;251 Royal Society of Chemistry, Cambridge.
8. Bolton S. Pharmaceutical Statistics, Practical and Clinical Applications. 3rd ed. 1997;Marcel Dekker, New York. Ch. 7, p. 239.
9. Hicks D.R., Wolaniuk D., Russell A., Cavanaugh N., Kraml M. Ther. Drug Monit. 16:(1):1994;100.
10. Kelly G.L., Murray L., Sifton D.W. PDR. 56th ed. 2002;1490 Medical Economics Company, Montvale, NJ.
11. Budavari S. The Merck Index. 13th ed. 2001;Merck, Whitehouse Station, NJ.